Takeda Pharmaceutical Co Ltd (TKPHF) Revenue (2017 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly Revenue of $7.7 billion for Q2 2026, little changed year-over-year from $7.6 billion in Q2 2025, and down 1.61% quarter-over-quarter from $7.8 billion in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) Revenue (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Revenue history runs 10 years deep, the most recent figure standing at $7.7 billion for Q2 2026.
- In Q2 2026, Revenue changed 0.07% year-over-year to $7.7 billion; the TTM figure through Jun 2026 stood at $46.5 billion (up 0.74% YoY), while the FY2026 annual figure was $29.9 billion, changed 0.48% from the prior year.
- Revenue for Q2 2026 stood at $7.7 billion, down from $7.8 billion in the prior quarter.
- The five-year high for Revenue was $23.9 billion in Q3 2025, with the low at $6.9 billion in Q4 2024.
- The 5-year median for Revenue is $7.8 billion (2022), against an average of $10.3 billion.
- The sharpest annual moves came in 2022 and 2023: Revenue decreased 13.32% in 2022, then jumped 206.56% in 2023.
- Takeda Pharmaceutical's Revenue stood at $7.8 billion in 2022, then dropped by 8.4% to $7.1 billion in 2023, then slipped by 2.54% to $6.9 billion in 2024, then increased by 2.64% to $7.1 billion in 2025, then advanced by 7.62% to $7.7 billion in 2026.
- Business Quant data shows TKPHF's Revenue at $7.7 billion in Q2 2026, $7.8 billion in Q1 2026, and $7.1 billion in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.65 Bn |
| Mar 31, 2026 | 7.78 Bn |
| Dec 31, 2025 | 7.11 Bn |
| Sep 30, 2025 | 23.95 Bn |
| Jun 30, 2025 | 7.65 Bn |
| Mar 31, 2025 | 7.92 Bn |
| Dec 31, 2024 | 6.93 Bn |
| Sep 30, 2024 | 23.65 Bn |
| Jun 30, 2024 | 7.76 Bn |
| Mar 31, 2024 | 8.15 Bn |
| Dec 31, 2023 | 7.11 Bn |
| Sep 30, 2023 | 22.25 Bn |
| Jun 30, 2023 | 7.72 Bn |
| Mar 31, 2023 | 8.00 Bn |
| Dec 31, 2022 | 7.76 Bn |
| Sep 30, 2022 | 7.26 Bn |
| Jun 30, 2022 | 7.52 Bn |
| Mar 31, 2022 | 8.37 Bn |
| Dec 31, 2021 | 7.93 Bn |
| Sep 30, 2021 | 7.67 Bn |